Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

Completed

Phase 2 Results

Summary of Purpose

The main objective of this study is to evaluate the safety, tolerability and pharmacokinetics of Cerebril™ in Cerebral Amyloid Angiopathy (CAA) patients who have had lobar cerebral hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2005.

1 Feb 2003 7 Mar 2003 Unavailable Unavailable 1 Mar 2003 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

Not available